Antidepressant-like effect of caffeic acid
Involvement of the cellular signaling pathways
DOI:
https://doi.org/10.1590/s2175-97902022e20023Keywords:
Caffeic acid; MAPK; PKA; PKC; MEKAbstract
Caffeic acid is a phenolic compound widely distributed in plants and beverages such as coffee. Although its mechanism of action is poorly understood, caffeic acid reportedly induces antidepressant-like and neuroprotective effects. This study aimed to investigate the involvement of cellular signaling pathways in acute antidepressant-like effect induced by caffeic acid in mice. All procedures were approved by the Institutional Animal Ethics Committee of the UNIVALI n. 021/2013. Female Swiss mice were administered with vehicle, caffeic acid (5 mg/ kg, p.o.), inhibitor (H-89, U0126, chelerythrine, or PD9859, i.c.v.) or caffeic acid plus inhibitor. The behavioral effects were evaluated 1h after the administration of compounds to mice using tail suspension test (TST) and open field test (OFT). The results showed that the antidepressant- like effect of caffeic acid in mice was possibly mediated by the activation of PKA, MEK 1/2, PKC and MAPK (as assessed using TST), without compromising their locomotor activity (as assessed using OFT). Our results demonstrated, at least in part, the pathways involved in the neuroprotective and behavioral effects of caffeic acid.
Downloads
References
Ampuero E, Rubio FJ, Falcon R, Sandoval M, Diaz-Veliz G, Gonzalez RE, et al. Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex. Neuroscience. 2010;169(1):98-108.
Búfalo MC, Ferreira I, Costa G, Francisco V, Liberal J, Cruz MT, et al. Propolis and its constituent caffeic acid suppress LPS-stimulated pro-inflammatory response by blocking NF-κB and MAPK activation in macrophages. J Ethnopharmacol. 2013;149(1):84-92.
Cai H, Huang X, Xu S, Shen H, Zhang P, Huang Y, et al. Discovery of novel hybrids of diaryl-1, 2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy. Eur J Med Chem. 2016;108:89-103.
Castrén E, Hen R. Neuronal plasticity and antidepressant action. Trends Neurosci. 2013;36(5):259-267.
Castrén E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis. 2017;97(Pt B):119-126.
Copik AJ, Baldyz A, Nguyen K, Sahdeo S, Ho H, Kosaka A, et al. Isoproterenol acts as a biased agonist of the alpha-1a-adrenoceptor that selectively activates the MAPK/ERK pathway. PLoS ONE.2015;10:e0115701.
Cunha MP, Budni J, Pazini FL, Oliveira A, Rosa JM, Lopes MW, et al. Involvement of PKA, PKC, CAMK-II and MEK1/2 in the acute antidepressant-like effect of creatine in mice. Pharmacol Rep. 2014;66:653-659.
Dalmagro AP, Camargo A, Zeni ALB. Morus nigra and it major phenolic, syringic acid, have antidepressant-like and neuroprotective effects in mice. Metab Brain Dis. 2017;32:1963-1973.
Hall S, Desbrow B, Anoopkumar-Dukie S, Davey AK, Arora D, McDermolt C, et al. A review of the bioactivity of coffee, caffeine and key coffee constituents on inflammatory responses linked to depression. Food Res Int. 2015;76:626-636.
Jiang JL, Peng YP, Qiu YH, Wang JJ. Adrenoreceptor-coupled signal-transduction mechanisms mediating lymphocyte apoptosis induced by endogenous catecholamines. J Neuroimmunol. 2009;213:100-111.
Kalonia H, Kumar P, Kumar A, Nehru B. Effect of caffeic acid and rofecoxib and their combination against intrastriatal quinolinic acid induced oxidative damage, mitochondrial and histological alterations in rats. Inflammopharmacology. 2009a;17:211-219.
Kalonia H, Kumar P, Kumar A, Nehru B. Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status. Neurosci Bull. 2009b;25:343-352.
Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, et al. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci. 2015;112:7833-7888.
Lee MS, Kim YH, Lee BR, Kwon SH, Moon WJ, Hong KS, et al. Novel antidepressant-like activity of caffeic acid phenethyl ester is mediated by enhanced glucocorticoid receptor function in the hippocampus. Evid Based Complement Alternat Med. 2014;2014:646039.
Maes M, Fisar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: Inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology . 2012;20:127-150.
Niciu MJ, Ionescu DF, Mathews DC, Richards EM, Zarate CA Jr. Second messenger/signal transduction pathways in major mood disorders: Moving from membrane to mechanism of action, part I: Major depressive disorder. CNS Spectr. 2013;18:231-41.
Noelker C, Bacher M, Gocke P, Wei X, Klockgether T, Du Y, et al. The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity. Neurosci Lett. 2005;383:39-43.
Otte C, Gold SM, Pennix BW, Pariante CM, Etkin A, Fava M, et al. Major Depressive Disorder. Nat Rev Dis Primers. 2016;2:1-20.
Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Conley RR. Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: A postmortem brain study. Arch Gen Psychiatry. 2004;61:685-693.
Scarparo AC, Visconti MA, Castrucci AM. Signalling pathways evoked by alpha(1)-adrenoceptors in human melanoma cells. Cell Biochem Funct. 2006;24:119-129.
Segura V, Perez-Aso M, Monto F, Carceller E, Noguera MA. Differences in the signaling pathways of α1A- and α1B-adrenoceptors are related to different endosomal targeting. PLoS ONE . 2013;8:e64996.
Steru L, Chermat R, Thiery B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367-370.
Takeda H, Tsuji M, Inazu M, Egashira T, Matsumiya T. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur J Pharmacol. 2002;449:261-267.
Takeda H, Tsuji M, Miyamoto J, Masuya J, Iimori M, Matsumiya T. Caffeic acid produces antidepressive and/ or anxiolytic-like effects through indirect modulation of the alpha1-adrenoceptor system in mice. Neuroreport. 2003;14(7):1067-1070.
Taram F, Winter AN, Linseman DA. Neuroprotection comparison of chlorogenic acid and its metabolites against mechanistically distinct cell death-inducing agents in cultured cerebellar granule neurons. Brain Res. 2016;1648:69-80.
Taylor C, Fricker AD, Devi LA, Gomes I. Mechanisms of action of antidepressants: From neurotransmitter systems to signaling pathways. Cell Signal. 2005;17:549-557.
Tenore GC, Daglia M, Orlando V, D’Urso E, Saadat SH, Novellino E, et al. Coffee and depression: A short review of literature. Curr Pharm Des. 2015;21:5034-5040.
World Health Organization. Depression and other commom mental disorders: Global health estimates. 2017. Geneva: World Health Organization.
Zeni ALB, Zomkowski ADE, Maraschin M, Rodrigues ALS, Tasca CI. Involvement of PKA, CaMKII, PKC, MAPK/ERK and PI3K in the acute antidepressant-like effect of ferulic acid in the tail suspension test. Pharmacol Biochem Behav. 2012;103:181-186.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
